Symposia

Laser Photonics Joins Brokk at Waste Management Symposia 2024

Retrieved on: 
Wednesday, March 6, 2024
Green Technology, Government Technology, Manufacturing, Defense, Environment, Other Defense, Sustainability, Contracts, Hardware, Technology, Energy, Other Manufacturing, Robotics, Machinery, Nuclear, Engineering, Machine Tools, Metalworking & Metallurgy, Chemicals, Plastics, Life, Symposia, Clean technology, MRO, Waste management, Decontamination, LPC, Phoenix Convention Center

Laser Photonics Corporation (LPC), a leading global developer of industrial laser systems for laser cleaning and other applications, announced today that it is joining Brokk , the world's leading manufacturer of remote-controlled demolition robots, at their booth during the Waste Management (WM) Symposia 2024 .

Key Points: 
  • Laser Photonics Corporation (LPC), a leading global developer of industrial laser systems for laser cleaning and other applications, announced today that it is joining Brokk , the world's leading manufacturer of remote-controlled demolition robots, at their booth during the Waste Management (WM) Symposia 2024 .
  • Laser Photonics will be bringing several of its laser cleaning systems to the event, including the newest version of its CleanTech 1500-CTHD laser cleaning system, which has been updated to be air-cooled with a much smaller, more portable form factor.
  • Where: Booth 131 at the Phoenix Convention Center, Phoenix, AZ
    CleanTech Laser Blasting products by Laser Photonics provide industry professionals with eco-friendly, cost-effective and time-efficient systems that are utilized for industrial cleaning.
  • The DefenseTech product line by Laser Photonics provides professionals in the defense industry with an MRO tool for corrosion control and prevention.

Daiichi Sankyo Showcases Progress in Developing New Standards of Care for Patients with Industry-Leading DXd ADC Portfolio Across Multiple Cancers at ESMO

Retrieved on: 
Monday, October 16, 2023
Pharmaceutical, Health, Oncology, Clinical Trials, Congress, Cancer, Daiichi Sankyo, Abstract, Update, Research, NSCLC, Breast cancer, HR, MD, Biliary tract, TSE, Lung cancer, Survival, R, European Society for Medical Oncology, ESMO, Ovarian cancer, ET, JST, DXD, Brain, Paced Auditory Serial Addition Test, Overalls, ADC, HER2, Patient, Fine chemical, Medical imaging, Pharmaceutical industry, Symposia

Three late-breaking abstracts, including two Presidential Symposia presentations, are among the more than 20 abstracts showcasing Daiichi Sankyo’s leadership and progress in developing new standards of care for patients with cancer.

Key Points: 
  • Three late-breaking abstracts, including two Presidential Symposia presentations, are among the more than 20 abstracts showcasing Daiichi Sankyo’s leadership and progress in developing new standards of care for patients with cancer.
  • Daiichi Sankyo will hold a virtual conference call for investors on Tuesday, October 24, 2023 at 8:00-9:30 am ET / 9:00-10:30 pm JST.
  • Executives from Daiichi Sankyo will provide an overview of the ESMO research data and address questions.
  • Highlights of late-breaking data across Daiichi Sankyo’s DXd ADC portfolio at 2023 ESMO include:

Rimini Street Presenting at Gartner® IT Symposium/Xpo™ Events Across the Globe

Retrieved on: 
Wednesday, September 20, 2023
Professional Services, Data Management, Business, Technology, Software, Networks, Internet, Information, Exhibition, Gartner, EVP, GVP, Street, Innovation, Multimedia, SAP, Evolving intelligent system, Oracle, Rimini Street Inc. v. Oracle USA Inc., Region, Cost, Salesforce, AWS, Nightclub, Management, Communications satellite, Growth, Symposia

CEO of Rimini Street, Seth Ravin, will be in attendance providing further insights into balancing operations and innovations.

Key Points: 
  • CEO of Rimini Street, Seth Ravin, will be in attendance providing further insights into balancing operations and innovations.
  • Join the Rimini Street executives in the following sessions:
    “From Cost Center to Profit Center: How to Evolve IT Systems into Engines,” Eric Helmer SVP and Chief Technology Officer, Rimini Street.
  • Visit Rimini Street’s website to learn more about the presentations and to schedule 1:1 meetings with Rimini Street executives at the Gartner IT Symposium/Xpo Barcelona.
  • RSVPs for 1:1 conversations with Rimini Street executives will be scheduled on a first come, first serve basis.

Alcon Announces its Largest-Ever Scientific Program at the 41st Congress of the ESCRS, Showcasing New Data and Innovation to Support Ophthalmic Surgical Teams

Retrieved on: 
Wednesday, September 6, 2023
Surgery, Health, Science, Research, Optical, DFU, Contraindication, IOP, Indian Institutes of Technology, Partnership, Surgeon, Medical device, Social impact, Vision system, 3D, Cataract, Ophthalmology, Symposia, Recycling, Intraocular pressure, Congress, Publication, Collection, Sustainability, DSM-IV codes, OCT, Plastic Bank, Health professional, ESG, Ecosystem, European Society of Clinical Microbiology and Infectious Diseases, IOL, NYSE, Pharmaceutical industry, Veterinary medicine, LASIK, Alcon

“Alcon is driven by our purpose to help people see brilliantly.

Key Points: 
  • “Alcon is driven by our purpose to help people see brilliantly.
  • Introducing cutting-edge innovation and breakthrough technology has helped us bring our purpose to life for more than 75 years,” said Sunil Vasanth, VP, Europe Surgical Franchise, Alcon.
  • Visitors may download clinical science publications, submit grant applications for Investigator-Initiated Trials (IITs) and apply for independent medical education support, among other activities.
  • Please note that product-related promotion of Medical Devices to non-HCPs may be subject to restrictions based on local rules and regulations.

Johnson & Johnson Vision announces launch of ELITA™ Platform to Correct Myopia with New SILK Procedure at the European Society of Cataract and Refractive Surgeons Congress

Retrieved on: 
Wednesday, August 30, 2023
Presbyopia, Johnson & Johnson Vision, Natural Resources, A4, Patient, Near-sightedness, Congress, Environment, Johnson, Element, EDOF, Small incision lenticule extraction, Ophthalmology, Cataract, Woman, Symposia, Abstract, The New Elite, Eye, Carbon, Lock (computer science), Intraocular lens, Cornea, Surgeon, SILK, Food, IIS, Recycling, Toronto Congress Centre, Astigmatism, European Society of Clinical Microbiology and Infectious Diseases, Health, Dentistry, Telescopic sight, Pharmaceutical industry, Software

LONDON, Aug. 30, 2023 /PRNewswire/ -- Johnson & Johnson Vision*, a global leader in eye health and part of Johnson & Johnson MedTechi, will announce the launch of a next-generation laser vision correction solution, the ELITATM Platform, at the 41st European Society of Cataract and Refractive Surgeons (ESCRS) congress, 8-12 September 2023. The congress will also showcase a range of breakthrough data, with over 30 abstracts supported by Johnson & Johnson Vision accepted for presentation.

Key Points: 
  • The congress will also showcase a range of breakthrough data, with over 30 abstracts supported by Johnson & Johnson Vision accepted for presentation.
  • The ELITATM Platform enables surgeons to perform refractive correction on patients with myopia, with or without astigmatism, using the new SILK (Smooth Incision Lenticule Keratomileusis) procedure.
  • The Johnson & Johnson Vision ESCRS Booth (#B202) will have live demonstration areas for surgeons to experience first-hand the ELITATM Femtosecond Laser as well as other leading Johnson & Johnson Vision products.
  • Additionally, attendees will be able to participate in the Toric VR Simulator experience alongside dry labs and meet the expert sessions at the booth and in the Johnson & Johnson Vision Lighthouse.

HMP Global Announces Landmark Acquisition of Neuroscience Education Institute (NEI)

Retrieved on: 
Tuesday, July 11, 2023
CME, Mills, SMASH, Elderly care, Depression, Education, NEI, Schizophrenia, Atrial fibrillation, ADHD, Psychopharmacology, Navage, Evolution, Research, Today, Doctor of Philosophy, CNS, Brain damage, Central nervous system, Congress, Student, Gold, Acquisition, MD, Patient, Faculty, Knowledge, Growth, Sleep, Addiction, Psychiatry, Mental health, News, Anxiety, Alzheimer's disease, PTSD, Disease, Nursing, Pharmaceutical industry, Management, Symposia

MALVERN, Pa., July 11, 2023 /PRNewswire/ -- HMP Global, a leading omnichannel healthcare education and events company, today announced it has entered into a definitive agreement to acquire Neuroscience Education Institute (NEI), a privately held medical education company, and distinguished leader in psychopharmacology-based CNS (Central Nervous System) education. Financial terms of the agreement were not disclosed.

Key Points: 
  • "Today marks a significant milestone as we add the NEI company into the HMP Global portfolio, continuing our evolution as the world's leading resource for healthcare education," said Jeff Hennessy, Chairman and CEO, HMP Global.
  • Under the terms of the agreement, NEI will become a fully owned subsidiary of HMP Global and operate as an independent entity as part of the HMP Global family of companies.
  • "We are enormously proud to be joining a well-run organization like HMP Global, with a purpose-driven commitment to education.
  • Armstrong Teasedale LLP provided legal counsel to NEI Global and Troutman Pepper LLP provided legal counsel to HMP Global.

Debbie's Dream Foundation: Curing Stomach Cancer Joins the 15th Annual International Gastric Cancer Congress in Japan for Patient Advocacy Session

Retrieved on: 
Thursday, May 4, 2023
Education, DDF, EST, IGCC, Patient, Translation, Bristol Myers Squibb, Stomach cancer, United Kingdom, Oncology, Title, JST, Pharmaceutical industry, Symposia

FORT LAUDERDALE, Fla., May 4, 2023 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer (DDF) is joining forces with the International Gastric Cancer Association for the 15th Annual International Gastric Cancer Congress (IGCC). DDF patient advocates will participate in the Patient Advocacy Session on Saturday, June 17, 2023, from 8 a.m. to 12 p.m. JST, from Yokohama, Japan. The half-day session will be live-cast in North America on Friday, June 16, 2023, at 7 p.m. EST, in Europe on Saturday, June 17, 2023, at 1 a.m., and in the United Kingdom on Saturday, June 17, 2023, at 12 a.m. It will feature various panel discussions and presentations highlighting patient advocacy programs, services, and resources to oncologists and aims to provide accurate information to patients and ensure that their views are reflected in their healthcare decision-making. The entire program will be simultaneously translated into different languages, including English, Japanese, Chinese, and Korean.

Key Points: 
  • FORT LAUDERDALE, Fla., May 4, 2023 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer (DDF) is joining forces with the International Gastric Cancer Association for the 15th Annual International Gastric Cancer Congress (IGCC).
  • DDF patient advocates will participate in the Patient Advocacy Session on Saturday, June 17, 2023, from 8 a.m. to 12 p.m. JST, from Yokohama, Japan.
  • "DDF is proud to partner with the 15th Annual IGCC in Japan to help bring patient advocacy to the forefront," said Andrea Eidelman, Chief Executive Officer of DDF.
  • The IGCC 2023 Advocacy Session is supported in part by DDF, My Gut Feeling of Canada, and KIBOUNOKAI of Japan.

Doheny Eye Institute Announces Upcoming Presentations at ARVO 2023 Annual Meeting

Retrieved on: 
Friday, April 21, 2023
Breakfast, ARVO, The Historic New Orleans Collection, Association for Research in Vision and Ophthalmology, AMD, Disease, Research, Ernest, RSVP, Doctor of Philosophy, Retinal pigment epithelium, Cell death, Annual general meeting, New Orleans Marriott, Diabetic retinopathy, CDT, Doheny Eye Institute, Ophthalmology, Symposia

PASADENA, Calif., April 21, 2023 (GLOBE NEWSWIRE) -- Doheny Eye Institute , one of the nation’s leading vision research institutions, announced that more than 30 of its scientists and clinician-scientists will present their latest research during the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting.

Key Points: 
  • PASADENA, Calif., April 21, 2023 (GLOBE NEWSWIRE) -- Doheny Eye Institute , one of the nation’s leading vision research institutions, announced that more than 30 of its scientists and clinician-scientists will present their latest research during the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting.
  • The meeting will take place April 23-27, 2023 in New Orleans at the Ernest N. Morial Convention Center.
  • Doheny Eye Institute and UCLA Stein Eye Institute will also be exhibiting onsite in a shared booth space, #737.
  • “Doheny Eye Institute remains at the forefront of groundbreaking research to conserve, preserve and restore eyesight in people, and we are eager to share our latest findings and insights at ARVO 2023,” said Deborah A. Ferrington, PhD, Chief Scientific Officer at Doheny Eye Institute.

ISHLT Annual Meeting & Scientific Sessions to Convene International Transplant Community Next Month

Retrieved on: 
Tuesday, March 14, 2023
Online, International Society for Heart and Lung Transplantation, Research, Heart, Society, Ethics, Annual general meeting, Grant, Convention, Cardiogenic shock, Abstract, CO, Symposia, Scientific programming language, Lung transplantation, Patient, Science, APN, CME, Health equity, FAAN, DCD, CAE, International Society, CMV, Doctor of Philosophy, Continuing medical education, Lung, Dentistry, MD

Chicago, IL, March 14, 2023 (GLOBE NEWSWIRE) -- The International Society for Heart and Lung Transplantation (ISHLT) will host its 43rd Annual Meeting & Scientific Sessions on 19-22 April, 2023 in Denver, CO USA.

Key Points: 
  • Chicago, IL, March 14, 2023 (GLOBE NEWSWIRE) -- The International Society for Heart and Lung Transplantation (ISHLT) will host its 43rd Annual Meeting & Scientific Sessions on 19-22 April, 2023 in Denver, CO USA.
  • “Over the past year, the Annual Meeting Program Planning Committee was hard at work developing a highly innovative, exciting, and educational Scientific Program,” said Howard Eisen, MD, ISHLT 2023 Scientific Program Chair.
  • As the flagship meeting of this community, the ISHLT Annual Meeting has something for everyone on the entire care team and is the gateway to the latest scientific advances.
  • “The ISHLT Annual Meeting is the focal point for ISHLT members and others who care for patients with advanced heart and lung disease, and the centerpiece of the ISHLT year,” said Greg Schultz, CAE, ISHLT CEO.

Immune-Onc Therapeutics to Showcase Leadership in Myeloid Biology and Drug Development at Upcoming Scientific and Investor Conferences

Retrieved on: 
Friday, March 3, 2023
Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Genetics, Clinical Trials, UC, Bone marrow, Morton, University of California, Medicine, Myeloid tissue, SAB, University, Biomedical Research, Therapy, United States Air Force Scientific Advisory Board, Communication, UC San Diego School of Medicine, Pharmacology, Symposia, Pathology, Biomedicine, Translational research, Immunotherapy, Vaccine, Communications satellite, Pharmaceutical industry

Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a private, clinical-stage cancer immunotherapy company developing novel biotherapeutics targeting myeloid checkpoints, announced today its plans to present on the company’s myeloid biology research and clinical stage programs at three upcoming scientific and investor conferences in March.

Key Points: 
  • Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a private, clinical-stage cancer immunotherapy company developing novel biotherapeutics targeting myeloid checkpoints, announced today its plans to present on the company’s myeloid biology research and clinical stage programs at three upcoming scientific and investor conferences in March.
  • The presentations will highlight the potential of Immune-Onc’s pipeline of first-in-class myeloid checkpoint inhibitors to transform current treatment approaches for blood cancers and solid tumors.
  • The Myeloid Network seeks to connect researchers worldwide to promote communication and advancement of research and medicine in the field of myeloid cell biology.
  • Dr. Liao will present a corporate overview on Tuesday, March 14 at 4:00 - 4:30 p.m.